VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 125 filers reported holding VERVE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,641,000 | -29.3% | 350,000 | 0.0% | 0.27% | -26.4% |
| Q2 2023 | $6,562,500 | +129927.7% | 350,000 | 0.0% | 0.37% | +10.8% |
| Q1 2023 | $5,047 | -25.5% | 350,000 | 0.0% | 0.33% | -26.7% |
| Q4 2022 | $6,773 | -100.0% | 350,000 | -41.7% | 0.45% | -68.6% |
| Q3 2022 | $20,610,000 | +92.5% | 600,000 | -14.4% | 1.44% | +77.9% |
| Q2 2022 | $10,707,000 | -33.0% | 700,710 | 0.0% | 0.81% | -34.0% |
| Q1 2022 | $15,990,000 | -60.9% | 700,710 | -36.8% | 1.23% | -49.5% |
| Q4 2021 | $40,897,000 | +25.2% | 1,109,224 | +56.4% | 2.43% | +83.3% |
| Q3 2021 | $32,667,000 | -19.5% | 709,224 | 0.0% | 1.33% | -3.8% |
| Q2 2021 | $40,594,000 | – | 709,224 | – | 1.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alphabet Inc. | 10,974,011 | $167,683,000 | 9.10% |
| ARCH Venture Management, LLC | 2,508,809 | $38,335,000 | 4.67% |
| Casdin Capital, LLC | 3,138,167 | $47,951,000 | 4.05% |
| M28 Capital Management LP | 178,500 | $2,727,000 | 3.06% |
| Redmile Group, LLC | 1,833,547 | $28,017,000 | 1.07% |
| Cormorant Asset Management, LP | 700,710 | $10,707,000 | 0.81% |
| Novo Holdings A/S | 927,100 | $14,166,000 | 0.70% |
| Pinz Capital Management, LP | 51,800 | $792,000 | 0.54% |
| PFM Health Sciences, LP | 845,186 | $12,914,000 | 0.49% |
| Artal Group S.A. | 400,000 | $6,112,000 | 0.33% |